Literature DB >> 21989077

PharmGKB summary: very important pharmacogene information for CYP1A2.

Caroline F Thorn1, Eleni Aklillu, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21989077      PMCID： PMC3346273          DOI： 10.1097/FPC.0b013e32834c6efd

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  50 in total

1.  Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.

Authors:  Samar I Hamdy; Masahiro Hiratsuka; Kaori Narahara; Naomi Endo; Mervat El-Enany; Nadia Moursi; Mohammed S-E Ahmed; Michinao Mizugaki
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

2.  Coffee, myocardial infarction, and CYP nomenclature.

Authors:  Magnus Ingelman-Sundberg; Sarah C Sim; Daniel W Nebert
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

3.  Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.

Authors:  Roza Ghotbi; Magnus Christensen; Hyung-Keun Roh; Magnus Ingelman-Sundberg; Eleni Aklillu; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2007-03-17       Impact factor: 2.953

4.  CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.

Authors:  Keh-Ming Lin; Hsiao-Hui Tsou; I-Ju Tsai; Mei-Chun Hsiao; Chin-Fu Hsiao; Chia-Yih Liu; Winston W Shen; Hwa-Sheng Tang; Chun-Kai Fang; Chi-Shin Wu; Shao-Chun Lu; Hsiang-Wei Kuo; Shu Chih Liu; Hsiu-Wen Chan; Ya-Ting Hsu; Jia-Ni Tian; Yu-Li Liu
Journal:  Pharmacogenomics       Date:  2010-11       Impact factor: 2.533

5.  Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption.

Authors:  Patrick Sulem; Daniel F Gudbjartsson; Frank Geller; Inga Prokopenko; Bjarke Feenstra; Katja K H Aben; Barbara Franke; Martin den Heijer; Peter Kovacs; Michael Stumvoll; Reedik Mägi; Lisa R Yanek; Lewis C Becker; Heather A Boyd; Simon N Stacey; G Bragi Walters; Adalbjorg Jonasdottir; Gudmar Thorleifsson; Hilma Holm; Sigurjon A Gudjonsson; Thorunn Rafnar; Gyda Björnsdottir; Diane M Becker; Mads Melbye; Augustine Kong; Anke Tönjes; Thorgeir Thorgeirsson; Unnur Thorsteinsdottir; Lambertus A Kiemeney; Kari Stefansson
Journal:  Hum Mol Genet       Date:  2011-02-28       Impact factor: 6.150

6.  Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans.

Authors:  M Nakajima; T Yokoi; M Mizutani; M Kinoshita; M Funayama; T Kamataki
Journal:  J Biochem       Date:  1999-04       Impact factor: 3.387

7.  Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.

Authors:  Chima Matsumoto; Osamu Ohmori; Takahiro Shinkai; Hiroko Hori; Jun Nakamura
Journal:  Psychiatr Genet       Date:  2004-12       Impact factor: 2.458

8.  Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.

Authors:  Keiji Takata; Junji Saruwatari; Naoyuki Nakada; Mizuna Nakagawa; Koichiro Fukuda; Fujiho Tanaka; Shinobu Takenaka; Shuichi Mihara; Toru Marubayashi; Kazuko Nakagawa
Journal:  Eur J Clin Pharmacol       Date:  2005-12-30       Impact factor: 2.953

9.  Coffee, CYP1A2 genotype, and risk of myocardial infarction.

Authors:  Marilyn C Cornelis; Ahmed El-Sohemy; Edmond K Kabagambe; Hannia Campos
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

10.  Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.

Authors:  Kathrin Klein; Stefan Winter; Miia Turpeinen; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2010-11-02       Impact factor: 5.810
View more
  25 in total

1.  Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries.

Authors:  Madelé van Dyk; Jean-Claude Marshall; Michael J Sorich; Linda S Wood; Andrew Rowland
Journal:  Eur J Clin Pharmacol       Date:  2018-03-23       Impact factor: 2.953

2.  Caffeinated Coffee and Tea Consumption, Genetic Variation and Cognitive Function in the UK Biobank.

Authors:  Marilyn C Cornelis; Sandra Weintraub; Martha Clare Morris
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

Review 3.  Bioinformatics and variability in drug response: a protein structural perspective.

Authors:  Jennifer L Lahti; Grace W Tang; Emidio Capriotti; Tianyun Liu; Russ B Altman
Journal:  J R Soc Interface       Date:  2012-05-02       Impact factor: 4.118

4.  Pharmacokinetics of Eltrombopag in Healthy Chinese Subjects and Effect of Sex and Genetic Polymorphism on its Pharmacokinetic and Pharmacodynamic Variability.

Authors:  Jinliang Chen; Yichao Xu; Honggang Lou; Bo Jiang; Rong Shao; Dandan Yang; Yin Hu; Zourong Ruan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-03-29       Impact factor: 2.441

5.  Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay.

Authors:  Olivia J Veatch; Julie S Pendergast; Melissa J Allen; Roberta M Leu; Carl Hirschie Johnson; Sarah H Elsea; Beth A Malow
Journal:  J Autism Dev Disord       Date:  2015-01

6.  CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.

Authors:  Natasa Djordjevic; Dragana Dragas Milovanovic; Marija Radovanovic; Ivan Radosavljevic; Slobodan Obradovic; Mihajlo Jakovljevic; Dragan Milovanovic; Jasmina R Milovanovic; Slobodan Jankovic
Journal:  Eur J Clin Pharmacol       Date:  2016-01-14       Impact factor: 2.953

7.  Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.

Authors:  Adrian Derungs; Massimiliano Donzelli; Benjamin Berger; Christoph Noppen; Stephan Krähenbühl; Manuel Haschke
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

8.  Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population.

Authors:  Fernando de Andrés; Catalina Altamirano-Tinoco; Ronald Ramírez-Roa; Carlos F Montes-Mondragón; Pedro Dorado; Eva M Peñas-Lledó; Adrián LLerena
Journal:  Pharmacogenomics J       Date:  2020-10-06       Impact factor: 3.550

9.  Recent consumption of a caffeine-containing beverage and serum biomarkers of cardiometabolic function in the UK Biobank.

Authors:  Marilyn C Cornelis
Journal:  Br J Nutr       Date:  2020-11-04       Impact factor: 3.718

Review 10.  Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations.

Authors:  Seenae Eum; Adam M Lee; Jeffrey R Bishop
Journal:  Dialogues Clin Neurosci       Date:  2016-09       Impact factor: 5.986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.